Quantified

APRIL 13, 2023

In 2023, sales training simulations address a new concern that sales managers are just beginning to face return anxiety. As employees return to work after extended periods of remote work or reenter the workforce after COVID-related interruptions, companies find they can resolve return anxiety through experiential learning. Sales training simulations fit the bill: they provide experience, let salespeople of all skill levels practice new-to-them skills, and foster an experiential learning environm

Training 52

Training Sales Prospecting Sales Management 52

PharmaVoice

APRIL 13, 2023

The COVID-19 pandemic highlighted an ongoing problem of vaccine hesitancy undermining public health efforts. One way pharmas can help is to change the narrative.

Pharma 59

Pharma 59

Fierce Pharma

APRIL 10, 2023

In upcoming skin disease clash, doctors see Novartis' Cosentyx as an underdog aliu Mon, 04/10/2023 - 15:53

Doctors 264

Doctors 264

MedCity News

APRIL 13, 2023

Virtual reality and podcasts are two innovative tools that can help captivate your audience and differentiate your healthcare brand. By utilizing these cutting-edge technologies, you can stay ahead of the competition and create more engaging marketing campaigns.

Healthcare 116

Healthcare Healthcare Marketing Competition 116

Advertisement

Distribution

European Pharmaceutical Review

APRIL 13, 2023

Psychedelics are a class of psychoactive substances that produce temporary changes in perception, mood and cognitive processes. 1 Some psychedelics are found in nature, including psilocybin, a naturally occurring molecule found in almost 150 species of mushrooms which turns into psilocin once ingested, causing psychedelic effects. Other psychedelics are man-made, such as lysergic diethylamide (LSD), which was first synthesised in 1938 by Albert Hofmann at a laboratory in Switzerland. 2 LSD is wi

Medicine 117

Medicine Food and Drug Administration Doctors Government 117

Pharmaceutical Technology

APRIL 14, 2023

Ghana’s Food and Drug Authority (FDA) has approved R21/Matrix-M malaria vaccine in children aged 5 to 36 months, marking the first regulatory clearance for the University of Oxford-developed vaccine in any country in the world. Serum Institute of India (SIIPL), manufacturer and licence holder of the vaccine, has been notified of the registration by Ghana’s FDA.

Manufacturing 111

Manufacturing FDA Food Safety 111

MedCity News

APRIL 14, 2023

A panel discussion at the annual Abarca Forward conference in Puerto Rico last month sought to identify some of the innovative financial approaches that can be applied to managing the high price of novel therapies. Conversations also addressed what payers need for these financing models to be sustainable.

Management 115

Management Biopharma Pharma 115

European Pharmaceutical Review

APRIL 10, 2023

The high reliability of matrix-assisted laser desorption/ionization (MALDI) time-of-flight (TOF) mass spectrometry (MS) systems for microbiological identification offer an alternative to serological-based methods, according to a review by researchers. “New technologies for the accurate and rapid identification of bacteria are essential in various fields of applied microbiology.

Media 111

Media Healthcare Healthcare Pharmaceutical 111

Pharmaceutical Technology

APRIL 13, 2023

Dyadic International has announced expansion of a licence agreement for its C1-cell protein expression platform with South African consortium Rubic One Health. The expanded licence will include the development of vaccines and therapeutic proteins beyond Covid-19 for human and animal health markets in Africa. During the Covid-19 pandemic, vaccination rates of many countries in Africa were significantly trailing the rest of the world.

Distribution 111

Distribution Manufacturing Media Marketing 111

Fierce Pharma

APRIL 13, 2023

Sickle cell disease gene therapies from Vertex, bluebird can be cost-effective at $1.

285

285

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Safety

MedCity News

APRIL 14, 2023

Ada Health recently announced that Jefferson Health is deploying its technology across its entire enterprise as part of a digital front door initiative. The Berlin-based company’s AI-powered symptom assessment and care navigation tools helps health systems achieve a robust digital front door, which means staff members don’t have to spend as much time triaging patients or helping them navigate the process of finding care.

Patients 113

Patients 113

European Pharmaceutical Review

APRIL 14, 2023

The current progress, challenges and opportunities for achieving stable formulations of nucleic acid (NA) therapeutics with novel drug delivery systems (DDSs) has been discussed in a paper published in Pharmaceutics. Over the past decade, the impact of nucleic acid (NA)-based biopharmaceuticals has been facilitated by breakthroughs associated with high-end manufacturing and pharmaceutical drug delivery.

Manufacturing 100

Manufacturing Pharmaceutical 100

Pharmaceutical Technology

APRIL 14, 2023

Clinical-stage biopharmaceutical company TORL BioTherapeutics has raised $158m in a Series B financing round for advancing the development of new biologics for cancer treatment. TORL BioTherapeutics is a newly formed, US-based company focused on the development of novel antibody-based therapeutics for cancer patients. Led by Goldman Sachs Asset Management, the financing round has also seen participation from Deep Track Capital, Moore Strategic Ventures, Cowen Healthcare Investments, Bristol Myer

Management 105

Management Leads Patients Healthcare 105

Fierce Pharma

APRIL 14, 2023

Ghana approves University of Oxford's malaria vaccine ahead of key WHO review zbecker Fri, 04/14/2023 - 11:13

248

248

Advertiser: ZoomInfo

Marketing technology is essential for B2B marketers to stay competitive in a rapidly changing digital landscape — and with 53% of marketers experiencing legacy technology issues and limitations, they’re researching innovations to expand and refine their technology stacks. To help practitioners keep up with the rapidly evolving martech landscape, this special report will discuss: How practitioners are integrating technologies and systems to encourage information-sharing between departments and pr

Competition

MedCity News

APRIL 14, 2023

The American Health Care Association and the National Center for Assisted Living reported in June that nearly half of the nation’s 14,000 nursing homes are facing severe labor shortages, and 73 percent of those facilities are concerned about closing.

112

112

PharmaTech

APRIL 11, 2023

A document signed by members of more than 400 companies and investment firms decries the decision made by a federal judge concerning mifepristone, a medication used in abortions.

Pharma 98

Pharma FDA Medical 98

Pharmaceutical Technology

APRIL 14, 2023

Ginkgo Bioworks (Ginkgo) and the Wisconsin Alumni Research Foundation (WARF) have collaborated to discover next-generation GD2 CAR T-cell therapies to treat solid tumours. WARF is the patenting and licensing organisation for the University of Wisconsin–Madison in the US. Ginkgo will partner with researchers from Wisconsin-Madison to discover new and improved GD2 CAR designs with improved persistence, fitness and proliferation.

Engineering 105

Engineering Patients Leads Pharmaceutical 105

Fierce Pharma

APRIL 14, 2023

FDA advisers back Lundbeck and Otsuka's Rexulti in Alzheimer's disease agitation zbecker Fri, 04/14/2023 - 18:14

FDA 244

FDA 244

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

MedCity News

APRIL 13, 2023

Hospital M&A activity remained strong during the first quarter of 2023, according to a new report from Kaufman Hall. Hospitals and health systems announced 15 M&A transactions in the first quarter of 2023, which almost matches the 17 transactions announced in the fourth quarter of 2022.

Healthcare 111

Healthcare Healthcare 111

ALULA

APRIL 13, 2023

Recently I attended the Women in Leadership panel at the American Manufacturing Summit. The panel included senior leaders from Caterpillar, Cummins, The Boeing Company, Kimberly-Clark Corporation, Philips, and Johnson & Johnson. The conversation focused on sharing personal experiences - both accomplishments and challenges - about being a woman and an executive in male-dominated industries.

Manufacturing 98

Manufacturing 98

Pharmaceutical Technology

APRIL 11, 2023

The US government is reportedly investing more than $5bn in a programme to accelerate the development of new Covid-19 vaccines and treatments. Dubbed Project Next Gen, the new effort will follow an approach similar to that of Operation Warp Speed, which developed and delivered vaccines to Covid-19 patients in 2020 by forming private-public partnerships for the rapid development of new vaccines.

Government 105

Government Marketing Patients 105

Fierce Pharma

APRIL 14, 2023

AACR: Patient deaths taint Roche's industry-first early-stage liver cancer readout for Tecentriq and Avastin aliu Fri, 04/14/2023 - 22:19

Patients 217

Patients 217

Advertisement

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

Distribution

MedCity News

APRIL 13, 2023

Mifepristone and misoprostol, two pills that are taken together to terminate a pregnancy, have been approved by the FDA since 2000. But access to these drugs have been in serious jeopardy this year, and a federal judge in Texas recently ruled to suspend the FDA’s decadeslong approval of mifepristone. The final outcome for abortion pill access in the U.S. is still unclear among confliction federal rulings — the issue will likely end up in the Supreme Court.

FDA 108

FDA 108

LEVO Health

APRIL 11, 2023

As a healthcare practice, your online reputation is crucial to attracting and retaining patients. With the rise of online review platforms, patients have a powerful voice in sharing their experiences with others. According to 2020 data, nearly 71% of people use online reviews as the first step to finding a new physician. Therefore, responding to positive and negative online reviews is essential to building trust, managing your reputation, and increasing patient engagement.

Patients 98

Patients Healthcare Healthcare Management 98

Pharmaceutical Technology

APRIL 10, 2023

The Malaysian Ministry of Health (MoH) has reportedly approved additional indication of Astrazeneca ’s Evusheld 100mg/ml solution for injection (Tixagevimab 100mg/ml and Cilgavimab 100mg/ml) for Covid-19 prevention. Health director-general Tan Sri Dr Noor Hisham Abdullah stated that the approval of Evusheld was granted at the 383rd Drug Control Authority (DCA) meeting.

Medicine 105

Medicine Patients Marketing 105

Fierce Pharma

APRIL 12, 2023

Moderna nabs a win in Arbutus patent case as appeals court upholds prior invalidation zbecker Wed, 04/12/2023 - 11:16

235

235

Advertisement

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

Safety

MedCity News

APRIL 11, 2023

VintaBio manufactures AAV and lentiviral vectors for entities pursuing clinical development of cell and gene therapies. The contract development manufacturing organization’s launch comes as demand for viral vectors continues to outpace the supply of these crucial components of the therapies.

Manufacturing 105

Manufacturing Biopharma Pharma 105

Copyright Clearance Center

APRIL 11, 2023

April 11, 2023 – Danvers, Mass. – CCC , a leader in advancing copyright, accelerating knowledge, and powering innovation, today announced it has signed a bilateral agreement with the Malaysia Reprographic Rights Centre (MARC) to support its operations and the development of copyright-compliant content consumption in Malaysia benefitting both rightsholders and content users.

Education 98

Education Training Marketing Management 98

Pharmaceutical Technology

APRIL 10, 2023

Aviceda Therapeutics (Aviceda) has entered into a strategic partnership with the Patrick G Johnston Centre for Cancer Research at Queen’s University Belfast (QUB) for the development of next-generation glyco-immune therapeutics. Aviceda’s HALOS (high-affinity ligands of sigelcs) nanotechnology platform leverages glycobiology to modulate the innate immune system to develop advanced breakthrough therapeutics, focusing on immuno-oncology.

Medicine 103

Medicine Medical 103

Fierce Pharma

APRIL 12, 2023

AACR: AstraZeneca offers first look at Imfinzi's resectable lung cancer showing, fueling a key debate aliu Wed, 04/12/2023 - 15:37

204

204

Advertiser: ZoomInfo

In times of economic uncertainty, account-based strategies are essential. According to several business analysts and practitioners, ABM is a necessity for creating more predictable revenue. Research shows that nearly three-quarters of marketers (74%) already have the resources needed to build successful ABM programs.

Marketing